Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins.

Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins. Biochem J. 2011 Oct 15; 439(2):299-311.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.